Attenuated virulence of Streptococcus agalactiae deficient in D‐alanyl‐lipoteichoic acid is due to an increased susceptibility to defensins and phagocytic cells
暂无分享,去创建一个
M. Baptista | P. Trieu-Cuot | E. Pellegrini | C. Poyart | F. Jaubert | M. Marceau | Marie‐Cécile Lamy
[1] Carmen Buchrieser,et al. Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease , 2002, Molecular microbiology.
[2] B. Neumeister,et al. Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. , 2002, The Journal of infectious diseases.
[3] S. Grinstein,et al. Determinants of the Phagosomal pH in Neutrophils* , 2002, The Journal of Biological Chemistry.
[4] F. Fiedler,et al. Formation of D‐alanyl‐lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes , 2002, Molecular microbiology.
[5] H. Courtney,et al. Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci , 2002, Annals of medicine.
[6] F. Fiedler,et al. Regulation of d-Alanyl-Lipoteichoic Acid Biosynthesis in Streptococcus agalactiae Involves a Novel Two-Component Regulatory System , 2001, Journal of bacteriology.
[7] M. Baptista,et al. Contribution of Mn-Cofactored Superoxide Dismutase (SodA) to the Virulence of Streptococcus agalactiae , 2001, Infection and Immunity.
[8] Michael Otto,et al. Staphylococcus aureus Resistance to Human Defensins and Evasion of Neutrophil Killing via the Novel Virulence Factor Mprf Is Based on Modification of Membrane Lipids with l-Lysine , 2001, The Journal of experimental medicine.
[9] T. Ganz,et al. Antimicrobial Proteins and Peptides , 2001 .
[10] Defects in D-alanyl-lipoteichoic acid synthesis in Streptococcus mutans results in acid sensitivity. , 2000, Journal of bacteriology.
[11] Robert Bals,et al. Epithelial antimicrobial peptides in host defense against infection , 2000, Respiratory research.
[12] O. Levy,et al. Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents. , 2000, Blood.
[13] J. Heitman. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases , 2000 .
[14] M. Kiriukhin,et al. Biosynthesis of Lipoteichoic Acid inLactobacillus rhamnosus: Role of DltD ind-Alanylation , 2000, Journal of bacteriology.
[15] Insertional Inactivation of Genes Responsible for thed-Alanylation of Lipoteichoic Acid inStreptococcus gordonii DL1 (Challis) Affects Intrageneric Coaggregations , 1999, Infection and Immunity.
[16] H. Kalbacher,et al. Inactivation of the dlt Operon inStaphylococcus aureus Confers Sensitivity to Defensins, Protegrins, and Other Antimicrobial Peptides* , 1999, The Journal of Biological Chemistry.
[17] V. Bafna,et al. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. , 1998, The Journal of clinical investigation.
[18] A. Schuchat. Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms , 1998, Clinical Microbiology Reviews.
[19] P. Berche,et al. Molecular characterization and expression analysis of the superoxide dismutase gene from Streptococcus agalactiae. , 1997, Gene.
[20] W. Fischer,et al. The absence of D-alanine from lipoteichoic acid and wall teichoic acid alters surface charge, enhances autolysis and increases susceptibility to methicillin in Bacillus subtilis. , 1997, Microbiology.
[21] C. Kozak,et al. Identification of CRAMP, a Cathelin-related Antimicrobial Peptide Expressed in the Embryonic and Adult Mouse* , 1997, The Journal of Biological Chemistry.
[22] M. P. Heaton,et al. The dlt operon in the biosynthesis of D-alanyl-lipoteichoic acid in Lactobacillus casei. , 1996, Microbial drug resistance.
[23] M. Perego,et al. Incorporation of D-Alanine into Lipoteichoic Acid and Wall Teichoic Acid in Bacillus subtilis , 1995, The Journal of Biological Chemistry.
[24] P. Berche. Bacteremia is required for invasion of the murine central nervous system by Listeria monocytogenes. , 1995, Microbial pathogenesis.
[25] H. G. Boman,et al. Peptide antibiotics and their role in innate immunity. , 1995, Annual review of immunology.
[26] R. van Furth,et al. Antimicrobial mechanisms: antimicrobial polypeptides of mononuclear phagocytes. , 1994, Immunology series.
[27] E. Groisman,et al. Resistance to host antimicrobial peptides is necessary for Salmonella virulence. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[28] C. von Hunolstein,et al. Lipoteichoic acid and M protein: dual adhesins of group A streptococci. , 1992, Microbial pathogenesis.
[29] H. Rosen,et al. Phagocytosis of opsonized oil droplets by neutrophils. Adaptation to a microtiter plate format. , 1991, Journal of immunological methods.
[30] W. Fischer,et al. On the basic structure of poly(glycerophosphate) lipoteichoic acids. , 1990, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[31] O. Leon,et al. Adherence of Streptococcus agalactiae to synchronously growing human cell monolayers without lipoteichoic acid involvement , 1988, Infection and immunity.
[32] W. Fischer. Physiology of lipoteichoic acids in bacteria. , 1988, Advances in microbial physiology.
[33] G. Teti,et al. Adherence of group B streptococci to adult and neonatal epithelial cells mediated by lipoteichoic acid , 1987, Infection and immunity.
[34] I. Maridonneau-Parini,et al. Identification of distinct activation pathways of the human neutrophil NADPH-oxidase. , 1986, Journal of immunology.
[35] L. Tomalty,et al. Experimental meningococcal infection in mice: a model for mucosal invasion , 1986, Infection and immunity.
[36] T. Nealon,et al. Role of cellular lipoteichoic acids in mediating adherence of serotype III strains of group B streptococci to human embryonic, fetal, and adult epithelial cells , 1984, Infection and immunity.
[37] T. Nealon,et al. Association of elevated levels of cellular lipoteichoic acids of group B streptococci with human neonatal disease , 1983, Infection and immunity.
[38] K. Warren,et al. Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing. , 1983, Journal of immunology.
[39] F. Fiedler,et al. Alanine ester-containing native lipoteichoic acids do not act as lipoteichoic acid carrier. Isolation, structural and functional characterization. , 1980, The Journal of biological chemistry.
[40] P. Ferrieri,et al. Production of bacteremia and meningitis in infant rats with group B streptococcal serotypes , 1980, Infection and immunity.
[41] K. Boyer,et al. Group B streptococcal infections. , 2002, Pediatrics in review.
[42] R. Bortolussi,et al. Dynamics of Escherichia coli infection and meningitis in infant rats , 1978, Infection and immunity.
[43] A. Katzenstein,et al. Pulmonary Changes in Neonatal Sepsis Due to Group B β-Hemolytic Streptococcus: Relation to Hyaline Membrane Disease , 1976 .
[44] E. Effmann,et al. A comparison of early-onset group B steptococcal neonatal infection and the respiratory-distress syndrome of the newborn. , 1976, The New England journal of medicine.
[45] A. Katzenstein,et al. Pulmonary changes in neonatal sepsis to group B beta-hemolytic Streptococcus: relation of hyaline membrane disease. , 1976, The Journal of infectious diseases.